We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Redhill Biopharma Ltd | NASDAQ:RDHL | NASDAQ | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.0007 | -0.16% | 0.4498 | 0.30 | 0.93 | 0.4674 | 0.4498 | 0.4674 | 173,901 | 05:00:05 |
RedHill Biopharma LTD.
|
||
(Name of Issuer)
|
||
Ordinary Shares
|
||
(Title of Class of Securities)
|
||
757468103
|
||
(CUSIP Number)
|
||
December 22
, 2016
|
||
(Date of Event Which Requires Filing of this Statement)
|
Check the following box to designate the rule pursuant to which the Schedule is filed:
|
*
|
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
|
1. |
Name of Reporting Person
Migdal Insurance & Financial Holdings Ltd
|
||
2. |
Check the Appropriate Box if a Member of a Group
(a)
x
(b)
o
|
||
3. |
SEC Use Only
|
||
4. |
Place of Organization
Israel
|
||
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:
|
5. |
Sole Voting Power
|
|
6. |
Shared Voting Power
7,352,039
Ordinary Shares (*) (**)
|
||
7. |
Sole Dispositive Power
|
||
8. |
Shared Dispositive Power
7,352,039
Ordinary Shares (*) (**)
|
||
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person
7,352,039
Ordinary Shares (*) (**)
|
||
10. |
Check if the Aggregate Amount in Row (9) Excludes Certain Shares
o
|
||
11. |
Percent of Class Represented by Amount in Row (9)
4.76
%***
|
||
12. |
Type of Reporting Person :
CO
|
|
(a)
|
Name of Issuer:
|
|
(b)
|
Address of Issuer’s Principal Executive Offices:
|
|
(d)
|
Title of Class of Securities:
|
|
Ordinary Shares, NIS 0.01 par value per share (the “Ordinary Shares”)
|
|
(e)
|
CUSIP Number:
|
|
757468103
|
Item 3.
|
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
|
|
Not Applicable.
|
Item 4.
|
Ownership
|
Item 5.
|
Ownership of Five Percent or Less of a Class
|
|
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☒
.
|
Item 6.
|
Ownership of More than Five Percent on Behalf of Another Person
|
|
Not Applicable.
|
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company
|
|
Not Applicable.
|
Item 8.
|
Identification and Classification of Members of the Group
|
|
Not Applicable.
|
Item 9. Notice of Dissolution of Group
|
|
Not Applicable.
|
Item 10. Certification
|
[SIGNATURE PAGE TO FOLLOW]
|
|
SIGNATURES
|
November 25, 2015
|
MIGDAL INSURANCE AND FINANCIAL HOLDINGS LTD.
BY: /s/
Eran Czerninski & Asaf Ashkenazy
authorized signatories of MIGDAL INSURANCE AND FINANCIAL HOLDINGS
LTD.
|
1 Year Redhill Biopharma Chart |
1 Month Redhill Biopharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions